RETINAL VEIN OCCLUSION

This early study tests a new drug, ANXV, in 12 adults with diabetic retinopathy or retinal vein occlusion. Participants receive five daily infusions over 4 months to check safety and whether it improves vision. The goal is to find the right dose for larger studies.

This study will follow about 1,000 people in China who are already receiving faricimab for diabetic macular edema, retinal vein occlusion, or wet age-related macular degeneration. Researchers will track vision changes, eye thickness, and treatment patterns over one year to see ho…

This early study tests a new dye called MB-102 for taking pictures of the blood vessels in the back of the eye. The goal is to see if it is safe and provides good images compared to the standard dye used today. About 10 adults with healthy eyes or conditions like diabetic retinop…

This study collects blood, tissue, and health information from 650 people with and without retinal diseases like age-related macular degeneration and diabetic retinopathy. The goal is to build a database and biobank for future research, not to provide treatment. Participants will…

This study looks at a protein called sCD160 in the eye fluids and blood of people with diabetic retinopathy or retinal vein occlusion. Researchers want to see if higher levels of this protein are linked to these eye conditions. The study involves 120 adults and uses blood and eye…

This study uses a special eye scan (OCT angiography) to take detailed pictures of blood vessels in the retina. Researchers will follow about 1,050 people with retinal diseases (like diabetic retinopathy) and healthy volunteers over time. The goal is to find better ways to detect …